# Validation of a Kinetic Model of Erlotinib

> **NCT02904850** · — · UNKNOWN · sponsor: **University Hospital, Strasbourg, France** · enrollment: 50 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **BIOLOGICAL:** group of patients

## Key facts

- **NCT ID:** NCT02904850
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-06
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2016-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02904850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02904850, "Validation of a Kinetic Model of Erlotinib". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02904850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*